Julius Middleton Wilder

Julius Middleton Wilder

Assistant Professor of Medicine

External Address: 
Department Of Medicine, Durham, NC 27710
Internal Office Address: 
Box 90120, Durham, NC 27708-0120
(919) 684-8111
Office Hours: 
Tuesdays - 9am- 5pmThursdays- 9am- 5pmFridays- 9am - 5pm

Selected Grants

GS-US-337-1431 awarded by Gilead Sciences, Inc. (Principal Investigator). 2015 to 2021

Gilead HCV Heart and Lung awarded by Gilead Sciences, Inc. (Principal Investigator). 2016 to 2018

Collins, LF, Chan, A, Zheng, J, Chow, S-C, Wilder, JM, Muir, AJ, and Naggie, S. "Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection." Open forum infectious diseases 5.1 (January 2018): ofx264-. Full Text Open Access Copy

Henson, JB, Patel, YA, Wilder, JM, Zheng, J, Chow, S-C, King, LY, and Muir, AJ. "Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis." Digestive diseases and sciences 62.11 (November 2017): 3200-3209. Full Text

Barrett, NJ, Vann, T, Wilder, J, ingraham, K, Worthy, V, Boyce, X, Reyes, R, Chirinios, M, Wigfall, P, Robinson, W, and Patierno, S. "Implementing a Health Equity Agenda at the Duke Cancer Institute." Oncology Issues September -October 2016 (September 1, 2016): 48-57. Open Access Copy

Wilder, JM, Oloruntoba, OO, Muir, AJ, and Moylan, CA. "Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 22.7 (July 2016): 895-905. Full Text Open Access Copy

Wilder, JM, and Wilson, JAP. "Racial and Ethnic Disparities in Colon Cancer Screening in North Carolina." North Carolina medical journal 77.3 (May 2016): 185-186. Full Text Open Access Copy

Wilder, JM, Jeffers, LJ, Ravendhran, N, Shiffman, ML, Poulos, J, Sulkowski, MS, Gitlin, N, Workowski, K, Zhu, Y, Yang, JC, Pang, PS, McHutchison, JG, Muir, AJ, Howell, C, Kowdley, K, Afdhal, N, and Reddy, KR. "Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data." Hepatology (Baltimore, Md.) 63.2 (February 2016): 437-444. Full Text Open Access Copy

Wilder, J, Saraswathula, A, Hasselblad, V, and Muir, A. "A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment." Journal of the National Medical Association 108.1 (February 2016): 24-29. Full Text Open Access Copy

Wilder, JM, and Muir, AJ. "Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes." Therapeutic advances in chronic disease 6.6 (November 2015): 314-327. (Review) Full Text Open Access Copy

Patel, K, and Wilder, J. "Fibroscan." Ed. B Bacon. Clinical Liver Disease 4.5 (November 2014): 97-101. Full Text

Wilder, J, and Patel, K. "The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease." Medical devices (Auckland, N.Z.) 7 (January 2014): 107-114. (Review) Full Text Open Access Copy


Henson, JB, Wilder, JM, Patel, YA, Zheng, J, Chow, S-C, King, LY, and Muir, AJ. "Phenotypic Differences in Primary Sclerosing Cholangitis by Age Group." October 2016.

Jeffers, LJ, Wilder, JM, Muir, AJ, Howell, C, Zhu, Y, Seyedkazemi, S, Yang, JC, Pang, PS, McHutchison, JG, and Reddy, KR. "Safety and Efficacy of Ledipasvir/Sofosbuvir Single-Tablet-Regimen in African Americans with Genotype 1 Chronic Hepatitis C Virus: A Retrospective Analysis of Phase 3 Studies." 2014.